Skip to content

Comparison of the Intraoperative and Postoperative Effects of Ultrasound-guided Erector Spina Plane Block and Posterior Quadratus Lumborum Block in Patients Undergoing Lumbar Stabilization Surgery

Comparison of the Intraoperative and Postoperative Effects of Ultrasound-guided Erector Spina Plane Block and Posterior Quadratus Lumborum Block in Patients Undergoing Lumbar Stabilization Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05845788
Enrollment
62
Registered
2023-05-06
Start date
2023-04-15
Completion date
2023-08-02
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erector Spina Plan Block, Opioid Consumption, Postprocedural Analgesia, Quadratus Lumborum Block

Brief summary

The investigators aimed to compare the effects of ultrasound guided erector spina plan block and posterior quadratus lumborum block on intraoperative and postoperative opioid consumption in patients who will undergo short segment lumbar stabilization surgery.

Detailed description

All participants will be monitored with ECG, SpO2, non-invasive blood pressure. In induction, 1mg/kg 2% lidocaine, 2-3mg/kg propofol, 1mcg/kg fentanyl, 2mg midazolam, 0.6 mg/kg rocuronium will be used. Anesthesia depth will be monitored with BIS (bispectral index), and anesthesia will be maintained with 50% oxygen-air mixture and sevoflurane. After patient intubation, invasive artery cannulation will be performed on the non-dominant hand, and the patients will be placed in a prone position. 20 cc bupivacaine of 0.25% will be administered to both regions bilaterally, by following the rules of asepsis, with a 10 cm pajunk needle accompanied by USG, the needle site will be confirmed with 3 mm saline. BIS will be kept in the range of 40-50 throughout the case, and invasive arterial monitoring will be performed. 1 g paracetamol, 1 mg/kg tramadol and 4 mg ondansetron will be administered to the patients 30 minutes before the end of the surgery. After appropriate extubation and wakefulness, patients will be transferred to the postoperative anesthesia care unit (PACU), where they will be followed for 24 hours. An intravenous (IV) patient-controlled analgesia device (PCA) containing 100ml of tramadol at a concentration of 4mg/cc will be inserted. No infusion will be given, and the bolus dose will be set to 20mg, with a lock time of 20 minutes. In the postoperative period, 50 mg of dexketoprofen will be administered every 8 hours. VAS values, vital signs, and possible opioid side effects of the patients at 0, 1, 2, 6, 12 and 24 hours will be recorded. After completing 24 hours, the patient will be separated from the IV PCA device and transferred to the service.

Interventions

PROCEDUREPeripheral nerve block

Ultrasound guided peripheral nerve block

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients who will undergo lumbar stabilization operation * Between the ages of 18-65 * Both genders * ASA I-III risk group

Exclusion criteria

* Patients who did not accept the study * Patients younger than 18 years old * Patients older than 65 years * Patients with an ASA score greater than III * Patients with an active infection in the area to be blocked * Patients with a long bleeding time * Those who are pregnant * Patients with kidney failure * Patients with liver failure * Patients with BMI\<18 and BMI\>30 * Those who are allergic to local anesthetics * Patients who have had previous lumbar surgery * Uncooperative or mentally retarded patients

Design outcomes

Primary

MeasureTime frameDescription
İntraoperative remifentanil consumptionAt the end of the intraoperative periodThe investigators aimed to compare intraoperative remifentanil consumption of two groups
Postoperative tramadol consumptionThe investigators will record at postoperative 0. hourThe investigators aimed to compare postoperative tramadol consumption of two groups

Secondary

MeasureTime frameDescription
Postoperative nausea and vomitingThe investigators will record within 24 hours postoperatively.Whether there is postoperative nausea and vomiting will be questioned by the investigators. Yes or no will be marked in the table.
Postoperative pruritusThe investigators will record within 24 hours postoperatively.Whether there is postoperative pruritus will be questioned by the investigators. Yes or no will be marked in the table.
Postoperative visual analog scaleThe investigators will record at postoperative 0. hourThe investigators aimed to compare patient's visual analog scales of two groups. The visual pain scale is measured with a ruler from 0 to 10 cm. 0 indicates no pain, 10 indicates severe pain.

Other

MeasureTime frameDescription
Postoperative pulse rateThe investigators will record at postoperative 0. hourThe investigators aimed to compare patient's pulse rates of two groups.
Change from baseline oxygen saturationThe investigators will record every 10 minutes until the end of the surgeryThe investigators aimed to compare patient's baseline oxygen saturation change of two groups
Postoperative oxygen saturationThe investigators will record at postoperative 0. hourThe investigators aimed to compare patient's intraoperative oxygen saturations of two groups
Postoperative sistolic and diastolic blood pressureThe investigators will record at postoperative 0. hourThe investigators aimed to compare patient's blood pressures of two groups
Change from baseline systolic and diastolic blood pressureThe investigators will record every 10 minutes until the end of the surgeryThe investigators aimed to compare patient's blood pressures change of two groups
Change from baseline pulse rateThe investigators will record every 10 minutes until the end of the surgeryThe investigators aimed to compare patient's intraoperative pulse rates change of two groups

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026